Repare Therapeutics logo

Repare Therapeutics

Repare Therapeutics is a synthetic Lethal Therapeutics founded in 2016 by Daniel Durocher, Agnel Sfeir and Frank Sicheri.

3

Funding Rounds

$150.5m

Money raised

Overview

Repare Therapeutics is a synthetic Lethal Therapeutics founded in 2016 by Daniel Durocher, Agnel Sfeir and Frank Sicheri.

Funding

Funding series

Funding Series Analysis

The company Repare Therapeutics has raised a total of $150.5m in funding over 3 rounds.

Key Insights:

  • Repare Therapeutics Series B round, September 2019: $82.5m
  • Repare Therapeutics Series A round, June 2017: $68m
Repare Therapeutics logo
Repare Therapeutics Series B round, September 2019 $82.5m
Repare Therapeutics logo
Repare Therapeutics Series A round, June 2017 $68m

Industries

Repare Therapeutics is active in the following industries:
  • Biomedical engineering
  • Genome editing
  • Precision Oncology
  • Cancer
  • Technology
  • Genomics
  • Medicine
  • Healthcare
  • Internal medicine
  • Biotechnology
  • Biology
  • Oncology
  • Engineering